Vpriv

Active Ingredient(s): Velaglucerase Alfa
FDA Approved: * February 26, 2010
Pharm Company: * SHIRE
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vpriv Overview

Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme.[1] It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.[2] Competitive pr...

Read more Vpriv Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Velaglucerase_alfa

Recent Vpriv Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Velaglucerase Alfa
  • Injection: 200units, 400 units/vial, 400units
  • Powder: 200 units/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vpriv: (1 result)

Sorted by National Drug Code
  • 54092-701 Vpriv 2.5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Shire Us Manufacturing Inc.

Other drugs which contain Velaglucerase Alfa or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA